IGT者发病率高,而且肥胖、高血压以及高脂血症患病率也较高,该人群心脑血管疾病发病危险性显著增加。因此,IGT阶段进行早期干预治疗势在必行。二甲双胍被认为是胰岛素增敏剂之一,能够改善胰岛素抵抗,对血糖、血压、血脂、肥胖等的有益作用均得以肯定。本文对二甲双胍在IGT治疗 The incidence of IGT is high, and the prevalence of obesity, hypertension and hyperlipidemia is also high, and the risk of cardiovascular and cerebrovascular diseases in this population is significantly increased. Therefore, early intervention in the IGT phase is imperative. Metformin is considered as one of the sensitizers of insulin, can improve insulin resistance, and has positive effects on blood sugar, blood pressure, blood fat, obesity and so on. This article treats metformin in IGT